May 16, 2019
This week's View explores the efficacy and safety outcomes for new-generation drug-eluting stents compared with bare-metal stents, the effects of beta-blockers and calcium antagonists on clinical outcomes in stable coronary artery disease, and a recent update on clinical trials of losartan with and without beta-blockers to block aneurysm growth in patients with Marfan syndrome.